Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease
Chemical Biology & Drug Design · 2024-02 · 103 (2)
DOI: 10.1111/cbdd.14482 ↗At a glance
Journal article in Chemical Biology & Drug Design, published online on 2024-02-20. Written by Efe Doğukan Dincel and 7 co-authors. Institution: Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey. Major MEDLINE topics: Carbonic Anhydrases, Alzheimer Disease. Cited 14 times so far (Crossref); 33 references. Funded by: Istanbul Üniversitesi.
Topics: Demenz
Abstract (original language)
In this project, non‐sulfonamide bistrifluoromethyl‐derived hydrazide‐hydrazones were synthesized as multi‐target‐directed ligands to treat Alzheimer's disease and then, the novel derivatives were characterized by diverse spectral methods. Acetylcholinesterase (AChE), and human carbonic anhydrase (hCA) inhibitory qualifications of these compounds were determined. The reported compounds ( 2a ‐ y ) were determined to be effective inhibitors of the hCA I, hCA II and AChE enzymes with K i values in the range of 1.130 ± 0.15–5.440 ± 0.93 μM for hCA I, 0.894 ± 0.05–6.647 ± 1.35 μM for hCA II, and 0.196 ± 0.03–4.222 ± 1.04 μM for AChE. In silico studies were also performed to illuminate the binding interactions.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey.
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, European University of Lefke, Mersin, Turkey.
- Faculty of Science, Department of Chemistry, Atatürk University, Erzurum, Turkey.
ORCID profiles: Efe Doğukan Dincel, Faika Başoğlu-Ünal
Funding
- Istanbul Üniversitesi
Cite
APA
Dincel, E. D., Başoğlu-Ünal, F., Kuran, E. D., Kayra, T., Aydın, N., Kanber, E., Gülçin, İ., & Ulusoy-Güzeldemirci, N. (2024). Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14482
Vancouver
Dincel ED, Başoğlu-Ünal F, Kuran ED, Kayra T, Aydın N, Kanber E, et al. Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14482
BibTeX
@article{Dincel2024,
author = {Dincel, Efe Doğukan and Başoğlu-Ünal, Faika and Kuran, Ebru Didem and Kayra, Tülay and Aydın, Nurcan and Kanber, Esmanur and Gülçin, İlhami and Ulusoy-Güzeldemirci, Nuray},
title = {Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease},
journal = {Chemical Biology & Drug Design},
year = {2024},
volume = {103},
number = {2},
doi = {10.1111/cbdd.14482}
}
EUVIMED